These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9528999)

  • 1. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J
    Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.
    James SY; Mercer E; Brady M; Binderup L; Colston KW
    Br J Pharmacol; 1998 Nov; 125(5):953-62. PubMed ID: 9846632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.
    Simboli-Campbell M; Narvaez CJ; van Weelden K; Tenniswood M; Welsh J
    Breast Cancer Res Treat; 1997 Jan; 42(1):31-41. PubMed ID: 9116316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089.
    Zhang X; Jiang F; Li P; Li C; Ma Q; Nicosia SV; Bai W
    Clin Cancer Res; 2005 Jan; 11(1):323-8. PubMed ID: 15671562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
    James SY; Mackay AG; Colston KW
    J Steroid Biochem Mol Biol; 1996 Jul; 58(4):395-401. PubMed ID: 8903423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.
    Valrance ME; Brunet AH; Welsh J
    Endocrinology; 2007 Oct; 148(10):4887-94. PubMed ID: 17628009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW; Mackay AG; James SY; Binderup L; Chander S; Coombes RC
    Biochem Pharmacol; 1992 Dec; 44(12):2273-80. PubMed ID: 1472092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo.
    Koshizuka K; Koike M; Asou H; Cho SK; Stephen T; Rude RK; Binderup L; Uskokovic M; Koeffler HP
    Breast Cancer Res Treat; 1999 Jan; 53(2):113-20. PubMed ID: 10326788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer.
    Milliken EL; Zhang X; Flask C; Duerk JL; MacDonald PN; Keri RA
    Cancer Lett; 2005 Nov; 229(2):205-15. PubMed ID: 16115727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
    Abe J; Nakano T; Nishii Y; Matsumoto T; Ogata E; Ikeda K
    Endocrinology; 1991 Aug; 129(2):832-7. PubMed ID: 1855478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice.
    Sundaram S; Sea A; Feldman S; Strawbridge R; Hoopes PJ; Demidenko E; Binderup L; Gewirtz DA
    Clin Cancer Res; 2003 Jun; 9(6):2350-6. PubMed ID: 12796405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
    Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
    Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant.
    Narvaez CJ; Welsh J
    Endocrinology; 1997 Nov; 138(11):4690-8. PubMed ID: 9348195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer.
    El Abdaimi K; Papavasiliou V; Rabbani SA; Rhim JS; Goltzman D; Kremer R
    Cancer Res; 1999 Jul; 59(14):3325-8. PubMed ID: 10416587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model.
    Akhter J; Chen X; Bowrey P; Bolton EJ; Morris DL
    Dis Colon Rectum; 1997 Mar; 40(3):317-21. PubMed ID: 9118747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.